Literature DB >> 27604659

Renal dysfunction and diastolic impairment among British ethnic minorities with hypertension: the Ethnic-Echocardiographic Heart of England Screening Study.

A Shantsila1, E Shantsila1, P S Gill2, G Y H Lip1.   

Abstract

Renal dysfunction is frequently associated with left ventricular (LV) hypertrophy and diastolic dysfunction in hypertensive patients. Limited data exist on renal dysfunction and diastolic impairment among British ethnic minorities with hypertension. We studied associations between renal impairment and diastolic dysfunction in hypertensive subjects of African-Caribbean and South Asian origin. Five hundred and ten hypertensive subjects with ejection fraction ⩾55% and with no history of ischaemic heart disease/valve pathology were included from the original population of the Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES). Diastolic function and cardiac remodelling were measured by echocardiography. LV hypertrophy was common and present in 62% of patients with normal estimated glomerular filtration rate (eGFR, >90 ml min-1 per 1.73 m2), 73% in those with eGFR 60-89 ml min-1 per 1.73 m2 and 87% with eGFR <60 ml min-1 per 1.73 m2. On both univariate and multivariable linear regression, reduced eGFR was associated with higher LV mass index (LVMI, P=0.01 and P=0.039, respectively). On multivariable analyses, increased LVMI (but not eGFR) was an independent predictor of echocardiographic parameters of diastolic dysfunction. Higher LVMI was an independent predictor of all-cause or cardiovascular death on multivariable analyses (both P=0.002), but not eGFR. LV hypertrophy is common in minority ethnic groups with hypertension, especially in the presence of renal dysfunction. Increased LVMI rather than renal impairment per se is a major determinant of diastolic dysfunction and increased risk of cardiovascular or all-cause death among hypertensive patients without end-stage renal failure.

Entities:  

Mesh:

Year:  2016        PMID: 27604659     DOI: 10.1038/jhh.2016.68

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  21 in total

Review 1.  Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling.

Authors:  Gerald W Dorn
Journal:  Cardiovasc Res       Date:  2008-09-08       Impact factor: 10.787

Review 2.  Left ventricular mass in chronic kidney disease and ESRD.

Authors:  Richard J Glassock; Roberto Pecoits-Filho; Silvio H Barberato
Journal:  Clin J Am Soc Nephrol       Date:  2009-12       Impact factor: 8.237

3.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.

Authors:  D Levy; R J Garrison; D D Savage; W B Kannel; W P Castelli
Journal:  N Engl J Med       Date:  1990-05-31       Impact factor: 91.245

4.  Role of aldosterone in left ventricular hypertrophy among African-American patients with end-stage renal disease on hemodialysis.

Authors:  Susan Steigerwalt; Abida Zafar; Nancy Mesiha; Julius Gardin; Robert Provenzano
Journal:  Am J Nephrol       Date:  2007-02-23       Impact factor: 3.754

5.  Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors.

Authors:  J D Harnett; R N Foley; G M Kent; P E Barre; D Murray; P S Parfrey
Journal:  Kidney Int       Date:  1995-03       Impact factor: 10.612

Review 6.  Cardiac consequences of hypertension in hemodialysis patients.

Authors:  Carmine Zoccali; Francesco Antonio Benedetto; Giovanni Tripepi; Francesca Mallamaci
Journal:  Semin Dial       Date:  2004 Jul-Aug       Impact factor: 3.455

7.  Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.

Authors:  Gregg C Fonarow; Wendy Gattis Stough; William T Abraham; Nancy M Albert; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Jie Lena Sun; Clyde W Yancy; James B Young
Journal:  J Am Coll Cardiol       Date:  2007-08-06       Impact factor: 24.094

8.  Impact of left ventricular hypertrophy on survival in end-stage renal disease.

Authors:  J S Silberberg; P E Barre; S S Prichard; A D Sniderman
Journal:  Kidney Int       Date:  1989-08       Impact factor: 10.612

Review 9.  Left ventricular hypertrophy in renal disease: beyond preload and afterload.

Authors:  Eberhard Ritz
Journal:  Kidney Int       Date:  2009-04       Impact factor: 10.612

10.  Prevalence of heart failure and atrial fibrillation in minority ethnic subjects: the Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES).

Authors:  Paramjit S Gill; Melanie Calvert; Russell Davis; Michael K Davies; Nick Freemantle; Gregory Y H Lip
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.